We recently released several exciting new editorial tools for academic channel editors, enabling them to more efficiently assign articles to editors, send promotional emails to their organization, and manage internal peer reviewer lists. This summer we'll be redesigning channel homepages to provide more opportunities to upload and post content, engage with your channel community and promote your organization.

Your channel homepage serves as a branded gateway to your organization’s Cureus content. Your hand-picked editors manage all content from submission to publication. With a customizable and easy-to-update design, your channel will reflect your brand while helping to attract physician referrals and promote the clinical and academic research performed by your members, faculty, residents or students.

Click below to learn more about how a Cureus academic channel can benefit your organization!

Looking for peer reviewers? Check out our Facebook group with over 1,300 members and meet other Cureus authors, discuss research, find peer reviewers and share Cureus research. Please feel free to make a post introducing yourself, your specialty, and any research you might be working on!

Thank you to everyone who applied for the volunteer associate editor position; we received over 200 applications in February alone! As the number of article submissions continues to increase, we are working to scale our editorial operations so that we can keep delivering on our promise of fast and efficient publication. If you haven't yet received a reply to your application email, please accept our sincere apologies for the delay as we are still working our way through them as time allows.

Cureus is calling for submissions related to psychoactive therapeutic drug treatments. Relevant original articles, case reports, review articles, and technical reports will be featured on a devoted Therapeutic Psychoactive Drug Treatments page and in an email campaign. Examples of psychoactive drugs include (but are not limited to) psilocybin, MDMA, LSD, DMT, and cannabinoids.

Add the keyword “Psychoactive Drug” to your submission to be included in the email campaign and newsroom page. The deadline for submissions is April 30th, 2022.